January 30, 2025
Robert F. Kennedy Jr. testified Thursday before the Senate health committee.
Anna Moneymaker/Getty Images

At confirmation hearing, RFK Jr. refuses to say that vaccines don’t cause autism

More than a dozen studies show that vaccination is not associated with autism, but the HHS nominee insisted sufficient data are not yet available.

By Rachel Cohrs Zhang and Matthew Herper


RFK Jr. endorses medications for opioid addiction at confirmation hearing, but misleads on 12-step programs

RFK Jr. also cast doubt on whether methadone and buprenorphine were truly the best available treatments for opioid addiction.

By Lev Facher


STAT+ | How AI helps drug developers skirt pharma’s ‘dirty little secret’

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

By Brittany Trang



Students walking on the Stanford campus, where the president has said some DEI programs likely will "need to be modified or ended."
Ben Margo/AP

STAT+ | Universities fear Trump is using lucrative research grants as leverage to dismantle their DEI programs

The anti-DEI plan focuses on "the center of resistance to Trump," a lawyer said, "particularly large research institutions in blue states."

By Usha Lee McFarling, Megan Molteni, and Jonathan Wosen


STAT+ | Takeda CEO Christophe Weber to step down following prolonged drop in company shares

Julie Kim, currently president of Takeda’s U.S. business unit, will succeed him, making her one of the few female chief executives in the pharma industry.

By Allison DeAngelis and Matthew Herper


Uganda confirms Ebola case in nurse in capital city

The fatal case was a 32-year-old nurse, who sought care at different health centers. Officials have identified more than 40 contacts.

By Andrew Joseph and Helen Branswell


Two medical staffers observe screens displaying live images of arteries during heart surgery.
Adobe

STAT+ | Cigna’s lower earnings reveal how sick American workers are

The company blamed lower than expected Q4 returns on its stop-loss insurance business that insures employers from catastrophically high medical claims.

By Bob Herman


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.